SCHEMBL4779407

SCHEMBL4779407

CCC(=O)N1CC=C(c2ccccc2CN2CCOCC2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 4/20 0.46
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
CYP2A13 Q16696 4/20 0.44
BRD4 O60885 1/20 0.40
KDM4E B2RXH2 3/20 0.39
MAPT P10636 2/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
DHODH Q02127 1/20 0.39
EED O75530 1/20 0.39
RBBP4 Q09028 1/20 0.39
SUZ12 Q15022 1/20 0.39
EZH2 Q15910 1/20 0.39
JAK1 P23458 1/20 0.39
CYP2C9 P11712 1/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4837899 0.89 NAMPT (0.46) NAMPTKMT2AMEN1CYP2A13BRD4
SCHEMBL4775570 0.76 AKR1C3 (0.42) CYP2A13
SCHEMBL27723067 0.75 ALDH1A1 (0.40) KMT2AMEN1CYP2A13BRD4KDM4E
SCHEMBL4775765 0.72 CYP2A13 (0.40) KMT2AMEN1CYP2A13BRD4KDM4E
SCHEMBL27723069 0.71 CYP2A13 (0.39) KMT2AMEN1CYP2A13BRD4KDM4E
SCHEMBL3436390 0.69 AKR1C3 (0.53) KMT2AMAPTALDH1A1LMNAGAA
SCHEMBL10150886 0.69 CYP2A13 (0.56) KMT2AMEN1CYP2A13KDM4EMAPT
SCHEMBL4108619 0.69 CYP2A13 (0.69) KMT2AMEN1CYP2A13KDM4EMAPT
SCHEMBL22324766 0.67 HRH3 (0.55) NAMPTKMT2AMEN1ALDH1A1
SCHEMBL11193326 0.67 CYP2A13 (0.75) KMT2AMEN1CYP2A13KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1996550-A2 CARBOXYAMINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF HDAC DEPENDENT DISEASES Novartis AG (CH) 2008-12-03 EP disclosed
WO-2007038459-A2 CARBOXYAMINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF HDAC DEPENDENT DISEASES NOVARTIS AG (CH) 2007-04-05 WO disclosed